Gyre Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Gyre Therapeutics, Inc. (GYRE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 31.46 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-09
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 31.46M shares, a 10.82% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 31.42M shares, a 42.04% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 31.38M shares, a 42.17% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 31.35M shares, a 75.22% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 30.64M shares, a 59.76% increase from fiscal 2020.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 19.18M shares, a 59.77% increase from fiscal 2019.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 12.00M shares, a 7.05% increase from fiscal 2018.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 11.21M shares, a 227.52% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 31.46M shares 10-Q · filed 2022-05-09 | 31.44M shares derived: average of 2 quarters · filed 2022-05-09 | 31.42M shares derived: average of 3 quarters · filed 2022-05-09 | 31.40M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2021-12-31 | 31.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 31.40M shares derived: average of 2 quarters · filed 2022-03-31 | 31.38M shares derived: average of 3 quarters · filed 2022-03-31 | 30.64M shares 10-K · filed 2022-03-31 | ||||
| 2021-09-30 | 31.38M shares 10-Q · filed 2021-11-12 | 31.36M shares derived: average of 2 quarters · filed 2021-11-12 | 30.38M shares 10-Q · filed 2021-11-12 | 28.31M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2021-06-30 | 31.35M shares 10-Q · filed 2021-08-05 | 29.88M shares 10-Q · filed 2021-08-05 | 27.28M shares derived: average of 3 quarters · filed 2022-05-09 | 25.98M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2021-03-31 | 28.39M shares 10-Q · filed 2022-05-09 | 25.25M shares derived: average of 2 quarters · filed 2022-05-09 | 24.19M shares derived: average of 3 quarters · filed 2022-05-09 | 22.62M shares derived: average of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | 22.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 22.10M shares derived: average of 2 quarters · filed 2022-03-31 | 20.69M shares derived: average of 3 quarters · filed 2022-03-31 | 19.18M shares 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | 22.07M shares 10-Q · filed 2021-11-12 | 19.98M shares derived: average of 2 quarters · filed 2021-11-12 | 18.20M shares 10-Q · filed 2021-11-12 | 16.65M shares derived: average of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | 17.89M shares 10-Q · filed 2021-08-05 | 16.24M shares 10-Q · filed 2021-08-05 | 14.84M shares derived: average of 3 quarters · filed 2021-08-05 | 14.14M shares derived: average of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | 14.59M shares 10-Q · filed 2021-05-06 | 13.32M shares derived: average of 2 quarters · filed 2021-05-06 | 12.89M shares derived: average of 3 quarters · filed 2021-05-06 | 12.66M shares derived: average of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | 12.04M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | 12.03M shares derived: average of 2 quarters · filed 2021-03-04 | 12.02M shares derived: average of 3 quarters · filed 2021-03-04 | 12.00M shares 10-K · filed 2021-03-04 | ||||
| 2019-09-30 | 12.02M shares 10-Q · filed 2020-11-05 | 12.01M shares derived: average of 2 quarters · filed 2020-11-05 | 11.99M shares 10-Q · filed 2020-11-05 | 11.98M shares derived: average of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | 11.99M shares 10-Q · filed 2020-08-06 | 11.98M shares 10-Q · filed 2020-08-06 | 11.97M shares derived: average of 3 quarters · filed 2020-08-06 | 11.96M shares derived: average of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | 11.96M shares 10-Q · filed 2020-05-11 | 11.96M shares derived: average of 2 quarters · filed 2020-05-11 | 11.95M shares derived: average of 3 quarters · filed 2020-05-11 | 11.95M shares derived: average of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | 11.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 11.95M shares derived: average of 2 quarters · filed 2020-02-20 | 11.94M shares derived: average of 3 quarters · filed 2020-02-20 | 11.21M shares 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | 11.94M shares 10-Q · filed 2019-11-07 | 11.94M shares derived: average of 2 quarters · filed 2019-11-07 | 10.97M shares 10-Q · filed 2019-11-07 | 9.36M shares derived: average of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | 11.94M shares 10-Q · filed 2019-08-01 | 10.47M shares 10-Q · filed 2019-08-01 | 8.50M shares derived: average of 3 quarters · filed 2019-08-01 | 7.45M shares derived: average of 4 quarters · filed 2019-08-01 | ||||
| 2018-03-31 | 8.99M shares 10-Q · filed 2019-05-02 | 6.78M shares derived: average of 2 quarters · filed 2019-05-02 | 5.95M shares derived: average of 3 quarters · filed 2019-05-02 | 5.44M shares derived: average of 4 quarters · filed 2019-05-02 | ||||
| 2017-12-31 | 4.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | 4.44M shares derived: average of 2 quarters · filed 2019-03-08 | 4.25M shares derived: average of 3 quarters · filed 2019-03-08 | 3.42M shares 10-K · filed 2019-03-08 | ||||
| 2017-09-30 | 4.31M shares 10-Q · filed 2018-11-01 | 4.09M shares derived: average of 2 quarters · filed 2018-11-01 | 3.04M shares 10-Q · filed 2018-11-01 | 2.47M shares derived: average of 4 quarters · filed 2018-11-01 | ||||
| 2017-06-30 | 3.88M shares 10-Q · filed 2018-08-02 | 2.40M shares 10-Q · filed 2018-08-02 | 1.86M shares derived: average of 3 quarters · filed 2018-08-02 | 1.59M shares derived: average of 4 quarters · filed 2018-08-02 | ||||
| 2017-03-31 | 906.05K shares 10-Q · filed 2018-05-03 | 853.79K shares derived: average of 2 quarters · filed 2018-05-03 | 832.46K shares derived: average of 3 quarters · filed 2018-05-03 | 815.13K shares derived: average of 4 quarters · filed 2018-05-03 | ||||
| 2016-12-31 | 801.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | 795.66K shares derived: average of 2 quarters · filed 2018-03-19 | 784.82K shares derived: average of 3 quarters · filed 2018-03-19 | 779.17K shares 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | 789.80K shares 10-Q · filed 2017-11-02 | 11.85M shares 10-Q · filed 2016-11-03 | 776.47K shares derived: average of 2 quarters · filed 2017-11-02 | 771.71K shares 10-Q · filed 2017-11-02 | 11.58M shares 10-Q · filed 2016-11-03 | -679.36K shares derived: average of 4 quarters · filed 2017-11-02 | ||
| 2016-06-30 | 763.14K shares 10-Q · filed 2017-08-03 | 11.45M shares 10-Q · filed 2016-08-04 | 762.57K shares 10-Q · filed 2017-08-03 | 11.44M shares 10-Q · filed 2016-08-04 | -1.17M shares derived: average of 3 quarters · filed 2017-08-03 | 475.90K shares derived: average of 4 quarters · filed 2017-08-03 | ||
| 2016-03-31 | 762.01K shares 10-Q · filed 2017-05-11 | 11.43M shares 10-Q · filed 2016-05-05 | -2.14M shares derived: average of 2 quarters · filed 2017-05-11 | 380.16K shares derived: average of 3 quarters · filed 2017-05-11 | 378.81K shares derived: average of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -5.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | 189.23K shares derived: average of 2 quarters · filed 2017-03-08 | 251.08K shares derived: average of 3 quarters · filed 2017-03-08 | 295.27K shares 10-K · filed 2017-03-08 | 4.43M shares 10-K · filed 2016-03-09 | |||
| 2015-09-30 | 5.41M shares 10-Q · filed 2016-11-03 | 2.89M shares derived: average of 2 quarters · filed 2016-11-03 | 2.07M shares 10-Q · filed 2016-11-03 | 9.99M shares derived: average of 4 quarters · filed 2016-11-03 | ||||
| 2015-06-30 | 374.76K shares 10-Q · filed 2016-08-04 | 33.89M shares 10-Q · filed 2015-07-31 | 373.63K shares 10-Q · filed 2016-08-04 | 33.84M shares 10-Q · filed 2015-07-31 | 11.51M shares derived: average of 3 quarters · filed 2016-08-04 | 8.73M shares derived: average of 4 quarters · filed 2016-08-04 | ||
| 2015-03-31 | 372.49K shares 10-Q · filed 2016-05-05 | 33.80M shares 10-Q · filed 2015-05-07 | 17.08M shares derived: average of 2 quarters · filed 2016-05-05 | 11.51M shares derived: average of 3 quarters · filed 2016-05-05 | 17.08M shares derived: average of 4 quarters · filed 2016-05-05 | |||
| 2014-12-31 | 33.79M shares 10-K · filed 2015-03-16 | 17.08M shares derived: average of 2 quarters · filed 2015-11-05 | 22.65M shares derived: average of 3 quarters · filed 2015-11-05 | 367.59K shares 10-K · filed 2016-03-09 | 33.78M shares 10-K · filed 2015-03-16 | |||
| 2014-09-30 | 368.46K shares 10-Q · filed 2015-11-05 | 33.79M shares 10-Q · filed 2014-11-06 | 17.08M shares derived: average of 2 quarters · filed 2015-11-05 | 366.45K shares 10-Q · filed 2015-11-05 | 33.78M shares 10-Q · filed 2014-11-06 | 25.39M shares derived: average of 4 quarters · filed 2015-11-05 | ||
| 2014-06-30 | 9.57M shares 8-K/A · filed 2015-10-23 | 9.57M shares 8-K/A · filed 2015-10-23 | 33.77M shares 10-Q · filed 2014-08-07 | 33.74M shares derived: average of 3 quarters · filed 2015-07-31 | 33.71M shares derived: average of 4 quarters · filed 2015-07-31 | |||
| 2014-03-31 | 33.75M shares 10-Q · filed 2015-05-07 | 33.71M shares derived: average of 2 quarters · filed 2015-05-07 | 33.69M shares derived: average of 3 quarters · filed 2015-05-07 | 33.67M shares derived: average of 4 quarters · filed 2015-05-07 | ||||
| 2013-12-31 | 33.67M shares 10-K · filed 2015-03-16 | 33.66M shares derived: average of 2 quarters · filed 2015-03-16 | 33.65M shares derived: average of 3 quarters · filed 2015-03-16 | 365.21K shares 10-K · filed 2016-03-09 | 33.64M shares 10-K · filed 2014-03-14 | |||
| 2013-09-30 | 33.64M shares 10-K · filed 2015-03-16 | 33.64M shares derived: average of 2 quarters · filed 2015-03-16 | 33.63M shares 10-Q · filed 2014-11-06 | |||||
| 2013-06-30 | 33.63M shares 10-K · filed 2015-03-16 | 33.62M shares 10-Q · filed 2014-08-07 | ||||||
| 2013-03-31 | 33.62M shares 10-K · filed 2015-03-16 | |||||||
| 2012-12-31 | 33.48M shares 10-K · filed 2015-03-16 | |||||||
| 2011-12-31 | 31.64M shares 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |